Innovation Pharmaceuticals Inc (IPIX)

[rmzport]

To me, it seems the really big news here is being overlooked...."Cellceutix executives met this week with staff of the FDA Division of Oncology Products 1 to discuss the Kevetrin Phase 1 study data, as well as a proposed design of a planned Phase 2 trial in patients with ovarian cancer that have resistance to platinum-based therapy.

The FDA has agreed with Cellceutix's plan to initiate such a trial, and based upon the data from the Phase 1 trial," Cellceutix has just received its first authorization by the FDA to advance it's first Kevetrin Ph 2 trial!